Compare CTS & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CTS | ATRC |
|---|---|---|
| Founded | 1896 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.4B |
| IPO Year | 1994 | 2005 |
| Metric | CTS | ATRC |
|---|---|---|
| Price | $59.13 | $27.63 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $51.17 |
| AVG Volume (30 Days) | 215.5K | ★ 787.4K |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.29% | N/A |
| EPS Growth | 15.87 | ★ 74.74 |
| EPS | ★ 0.59 | N/A |
| Revenue | ★ $541,318,000.00 | $201,630,000.00 |
| Revenue This Year | $5.55 | $15.27 |
| Revenue Next Year | $5.00 | $12.21 |
| P/E Ratio | $101.42 | ★ N/A |
| Revenue Growth | 4.95 | ★ 15.40 |
| 52 Week Low | $36.03 | $26.62 |
| 52 Week High | $60.82 | $43.18 |
| Indicator | CTS | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 67.96 | 43.05 |
| Support Level | $41.09 | $27.68 |
| Resistance Level | $59.66 | $30.75 |
| Average True Range (ATR) | 2.11 | 1.57 |
| MACD | 0.29 | 0.04 |
| Stochastic Oscillator | 79.12 | 32.58 |
CTS Corp operates in the electronics industry. The company is a manufacturer of Sensors, Electronic components, and Actuators. It designs, manufactures, and sells a broad line of sensors, electronic components, and actuators mainly to original equipment manufacturers (OEMs) for the aerospace and defense, industrial, information technology, medical, telecommunications, and transportation markets. Geographically, it derives a majority of its revenue from the United States and also has a presence in China, Singapore, the Czech Republic, Taiwan, Denmark, and other countries.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.